Related references
Note: Only part of the references are listed.Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis
Erin J. J. Stringfellow et al.
JOURNAL OF ADDICTION MEDICINE (2023)
Estimating the impact of the COVID-19 pandemic on rising trends in drug overdose mortality in the United States, 2018-2021
Hyunjung Lee et al.
ANNALS OF EPIDEMIOLOGY (2023)
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Don Husereau et al.
VALUE IN HEALTH (2022)
Forecasted and Observed Drug Overdose Deaths in the US During the COVID-19 Pandemic in 2020
Abigail R. Cartus et al.
JAMA NETWORK OPEN (2022)
Modeling the evolution of the US opioid crisis for national policy development
Tse Yang Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis
Erin J. Stringfellow et al.
SCIENCE ADVANCES (2022)
Projected Estimates of Opioid Mortality After Community-Level Interventions
Benjamin P. Linas et al.
JAMA NETWORK OPEN (2021)
COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020
Joseph Friedman et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2021)
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic
Catherine DiGennaro et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2021)
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
Janet M. Currie et al.
JAMA NETWORK OPEN (2021)
Trends in Drug Overdose Mortality in Ohio During the First 7 Months of the COVID-19 Pandemic
Janet M. Currie et al.
JAMA NETWORK OPEN (2021)
Mortality From Drug Overdoses, Homicides, Unintentional Injuries, Motor Vehicle Crashes, and Suicides During the Pandemic, March-August 2020
Jeremy S. Faust et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic
Tami L. Mark et al.
JAMA NETWORK OPEN (2021)
Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder
Arthur Robin Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States
Jamey J. Lister et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2020)
America's opioid crisis: the need for an integrated public health approach
Carlos Blanco et al.
TRANSLATIONAL PSYCHIATRY (2020)
The HEALing (Helping to End Addiction Long-termSM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices
Sharon L. Walsh et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies
Carolina Barbosa et al.
VALUE IN HEALTH (2020)
Addressing opioid overdose deaths: The vision for the HEALing communities study
Redonna K. Chandler et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US
Jeromie Ballreich et al.
JAMA NETWORK OPEN (2020)
Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
Katherine Mackey et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
Sarah E. Wakeman et al.
JAMA NETWORK OPEN (2020)
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Qiushi Chen et al.
JAMA NETWORK OPEN (2019)
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
Rebecca L. Haffajee et al.
JAMA NETWORK OPEN (2019)
Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees
Amanda J. Abraham et al.
HEALTH SERVICES RESEARCH (2018)
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses A Systematic Review
David S. Fink et al.
ANNALS OF INTERNAL MEDICINE (2018)
Barriers to Medications for Addiction Treatment: How Stigma Kills
Sarah E. Wakeman et al.
SUBSTANCE USE & MISUSE (2018)
The changing landscape of naloxone availability in the United States, 2011-2017
Patricia R. Freeman et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis
Joshua A. Barocas et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Hillary Samples et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
Jake R. Morgan et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies
Khary K. Rigg et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Geographic Variation in Opioid and Heroin Involved Drug Poisoning Mortality Rates
Christopher J. Ruhm
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2017)
Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10US States
Patience Moyo et al.
ADDICTION (2017)
Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation
Rebecca McDonald et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations
George Jay Unick et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates
Stephen W. Patrick et al.
HEALTH AFFAIRS (2016)
A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction
Karen Dugosh et al.
JOURNAL OF ADDICTION MEDICINE (2016)
Retention in medication-assisted treatment for opiate dependence: A systematic review
Christine Timko et al.
JOURNAL OF ADDICTIVE DISEASES (2016)
The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings
Deborah S. Hasin et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2015)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
Natasha K. Stout et al.
PHARMACOECONOMICS (2009)
Share Paper
